Copyright
©The Author(s) 2024.
World J Clin Pediatr. Jun 9, 2024; 13(2): 89224
Published online Jun 9, 2024. doi: 10.5409/wjcp.v13.i2.89224
Published online Jun 9, 2024. doi: 10.5409/wjcp.v13.i2.89224
Factor | Description | |
Genetics | Specific genes mutations | Genes related to testosterone production and androgen receptor function. Genes associated with the genital tubercle development |
AIS | ||
Genetic deficiencies in Enzymes Involved in Hormone Production e.g., 5 alpha-reductase deficiency | ||
Genetic abnormalities affecting hormonal signalling | ||
Genetic disorders affecting pituitary gland function | ||
Genetic causes of congenital adrenal hyperplasia (deficiency in steroidogenic acute regulatory protein (STAR gene mutation), 3 beta-hydroxysteroid dehydrogenases (salt-wasting, non-salt-wasting, and non-classic types), 17 α-hydroxylase (mutations in the CYP17A1 gene located on chromosome 10q24-q25) | ||
Chromosomal Abnormalities e.g., Klinefelter syndrome (XXY), Trisomy of the chromosomes 8, 13, 18 or 21 | ||
Inherited syndromes | Bardet-Biedl syndrome, Prader-Willi syndrome and Kallman syndrome (hypogonadotropic hypogonadism, osteoporosis, hearing impairment, and anosmia). Noonan syndrome (hypertelorism, short neck, low-set ears, skeletal malformation, bleeding disorders, and pulmonary valve stenosis). Others: Charge syndrome, Silver Russel syndrome, Rud syndrome | |
Hormonal and endocrinal causes | Primary Hypogonadism: Either congenital or acquired e.g., Anorchia, Klinefelter and poly-X syndromes, gonadal dysgenesis (incomplete form), luteinizing hormone receptor defect (incomplete form), testosterone steroidogenesis (incomplete form), Noonan syndrome, Trisomy 21, Robinow syndrome, Bardet-Biedl syndrome, Laurence-Moon syndrome | |
Secondary Hypogonadism: Secondary to pituitary gland or hypothalamus disorders, resulting in decreased secretion of luteinizing hormone and follicle-stimulating hormone | ||
AIS | ||
Enzyme deficiencies affect testosterone synthesis or its conversion to the more potent dihydrotestosterone | ||
Growth hormone deficiency or abnormalities in IGF-1 | ||
Hypothyroidism | ||
Adrenal gland disorders such as adrenal hyperplasia | ||
Anatomical and structural abnormalities | Penis agenesis, cloacal dystrophy, hypospadias or chordee, Peyronie's disease, corpus cavernosa and corpus spongiosum hypoplasia, vascular abnormalities, ligaments or connective tissue abnormalities, and inadequate penile shaft length | |
Environmental factors | Antenatal exposure | Endocrine-disrupting chemicals, including phthalates, bisphenol A, and certain pesticides |
Anti-androgenic drugs | ||
Maternal substance abuse, including alcohol, drugs, or tobacco | ||
Ionizing radiation | ||
Antenatal infections | ||
Inadequate nutrition and a poor maternal diet | ||
Pollutant exposure such as heavy metals and dioxins. | ||
Antenatal exposure of antifungal | ||
Postnatal exposure | Improper or excessive use of antibiotics or hormonal medications | |
Hormonal treatments for conditions like precocious puberty or delayed puberty | ||
Surgical interventions or treatments for disorders affecting the genitalia | ||
Idiopathic | Unknown cause |
- Citation: Al-Beltagi M, Saeed NK, Bediwy AS, Shaikh MA, Elbeltagi R. Microphallus early management in infancy saves adulthood sensual life: A comprehensive review. World J Clin Pediatr 2024; 13(2): 89224
- URL: https://www.wjgnet.com/2219-2808/full/v13/i2/89224.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v13.i2.89224